tirzepatide fda approved for weight loss Specialist Near Me in San Antonio, TX Tirzepatide, the new FDA approved

Nausea is one of the most common side effects of tirzepatide therapy, particularly during the early weeks and during dose escalations

The European Centre for Disease Prevention and Control also highlighted the growing chronic disease burden associated with obesity and diabetes, positively supporting semaglutide demand across European healthcare systems

Others lose significant weight at lower doses and do not need to escalate as aggressively

Low Blood Sugar While relatively uncommon, there exists a potential risk of low blood sugar levels (hypoglycemia), particularly when used alongside other medications that lower blood sugar